Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke.
Paulo Ávila-GómezMaría Pérez-MatoPablo HervellaAntonio Dopico-LópezAndrés da Silva-CandalAna Bugallo-CasalSonia López-AmoedoMaría Candamo-LouridoTomás SobrinoRamón Iglesias-ReyJosé CastilloFrancisco CamposPublished in: Journal of clinical medicine (2022)
This clinical study demonstrates the association between RBM3 and FGF21 levels and the outcome of stroke patients. Although further investigations are required, these data support the pharmacological induction of RBM3 as a promising protective therapy.